Table 2_Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor–related pneumonitis in lung cancer patients.docx

Table 2_Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor–related pneumonitis in lung cancer patients.docx

Background<p>Predictors for checkpoint inhibitor-related pneumonitis (cinrPneumonitis) are desperately needed. This study aimed to investigate the pretreatment standardized uptake value (SUV) on [<sup>18</sup>F]FDG-PET/CT of non-tumorous lung tissue as a predictive imaging marker f...

Full description

Saved in:
Bibliographic Details
Main Author: Friederike Völter (22090277) (author)
Other Authors: Lukas Wehlte (22090280) (author), Blerina Resuli (15143834) (author), Julia Walter (3321750) (author), Lea Daisenberger (22090283) (author), Maria Ingenerf (15356163) (author), Maurice Heimer (5815010) (author), Matthias Brendel (694662) (author), Gabriel T. Sheikh (15235850) (author), Lena M. Unterrainer (15235859) (author), Diego Kauffmann-Guerrero (11415837) (author), Thomas Pfluger (770033) (author), Lucie Heinzerling (654385) (author), Amanda Tufman (6832127) (author)
Published: 2025
Subjects:
Oncology and Carcinogenesis not elsewhere classified
lung cancer
NSCLC
SCLC
[18F]FDG-PET/CT
standardized uptake value
checkpoint inhibitor therapy
checkpoint inhibitor-related pneumonitis
immune-related adverse events
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items